by Sebastian | Jan 10, 2023 | News
Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated funds and coming up with deals that compensate them for the uncertainty involved. These firms are seeking to capitalize...
by Sebastian | Jan 10, 2023 | News
Private equity giant Vista Equity Partners has announced plans to take Duck Creek Technologies private in a $2.6bn deal. Boston-based Duck Creek, a SaaS-based software provider for the property and casualty (P&C) insurance sector, went public back in 2020,...
by Sebastian | Jan 10, 2023 | News
A report released today by Bloomberg news, a trusted and credible news source, suggests that Qatar Sports Investors are considering Liverpool along side Manchester United and Tottenham Hotspurs. It’s widely acknowledged that QSI is owned by the Qatari government...
by Sebastian | Jan 9, 2023 | News
Dextra Partners announced its formation as an independent, multi-strategy investment firm focused on providing investors with differentiated middle market private equity opportunities. Headquartered in New York, the Firm has been established with $2.5 billion of...
by Sebastian | Jan 9, 2023 | News
Andera Partners announced that its portfolio company Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, closed a $138M Series C equity financing. The financing was led by Sofinnova Partners and...
